Literature DB >> 16268965

Systematic review: acute colonic pseudo-obstruction.

M D Saunders1, M B Kimmey.   

Abstract

Acute colonic pseudo-obstruction is the clinical syndrome of acute large bowel dilatation without mechanical obstruction that is an important cause of morbidity and mortality. Acute colonic pseudo-obstruction occurs in hospitalized or institutionalized patients with serious underlying medical and surgical conditions. The pathogenesis of acute colonic pseudo-obstruction is not completely understood but likely results from an imbalance in the autonomic regulation of colonic motor function. Metabolic or pharmacological factors, as well as spinal or retroperitoneal trauma, may alter the autonomic regulation of colonic function, leading to excessive parasympathetic suppression or sympathetic stimulation. This imbalance results in colonic atony and dilatation. Early recognition and appropriate management are critical to minimizing morbidity and mortality. The mortality rate is estimated at 40% when ischaemia or perforation occurs. The best-studied treatment of acute colonic pseudo-obstruction is intravenous neostigmine, which leads to prompt colon decompression in the majority of patients after a single infusion. In patients failing or having contraindications to neostigmine, colonoscopic decompression is the active intervention of choice. Surgery is reserved for those with peritonitis or perforation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16268965     DOI: 10.1111/j.1365-2036.2005.02668.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  38 in total

1.  Colonoscopic decompression should be used before neostigmine in the treatment of Ogilvie's syndrome.

Authors:  K D Peker; M Cikot; M A Bozkurt; B Ilhan; B Kankaya; S Binboga; H Seyit; H Alis
Journal:  Eur J Trauma Emerg Surg       Date:  2016-07-18       Impact factor: 3.693

Review 2.  Gastrointestinal motility in acute illness.

Authors:  Sonja Fruhwald; Peter Holzer; Helfried Metzler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Management of Colonic Pseudo-obstruction.

Authors:  Michael D Saunders
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-12

4.  [The Ogilvie syndrome in a severely burned patient].

Authors:  S Siah; H Seddik; K Ababou; H Ihrai; N Drissi Kamili
Journal:  Ann Burns Fire Disasters       Date:  2011-09-30

5.  Acute colonic pseudo-obstruction following allogeneic stem cell transplantation successfully treated by neostigmine.

Authors:  Seung-Ah Yahng; Jae-Ho Yoon; Seung-Hwan Shin; Sung-Eun Lee; Ki-Seong Eom; Yoo-Jin Kim
Journal:  Blood Res       Date:  2013-06-25

Review 6.  [Acute colonic pseudo-obstruction: Ogilvie syndrome].

Authors:  J Keller; P Layer
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-09-23       Impact factor: 0.840

7.  Role of the BK channel (KCa1.1) during activation of electrogenic K+ secretion in guinea pig distal colon.

Authors:  Jin Zhang; Susan T Halm; Dan R Halm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-11       Impact factor: 4.052

8.  Advances and challenges in the management of acute colonic pseudo-obstruction (ogilvie syndrome).

Authors:  Arpana Jain; H David Vargas
Journal:  Clin Colon Rectal Surg       Date:  2012-03

9.  Intramuscular neostigmine and glycopyrrolate safely accelerated bowel evacuation in patients with spinal cord injury and defecatory disorders.

Authors:  Alan S Rosman; Geeta Chaparala; Amit Monga; Ann M Spungen; William A Bauman; Mark A Korsten
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

10.  Neostigmine and glycopyrronium: a potential safe alternative for patients with pseudo-obstruction without access to conventional methods of decompression.

Authors:  Alfred Adiamah; Sarah Johnson; Adrian Ho; James Orbell
Journal:  BMJ Case Rep       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.